STOCK TITAN

Translational Dev Acquisition (TDACU) Stock Price, News & Analysis

TDACU NASDAQ

Company Description

Translational Dev Acquisition (NASDAQ: TDACU) is classified in the shell companies industry within the Blank Checks sector.

TDACU has gained 10.7% over the past year. Shares last traded at $11.55.

For FY2025, Translational Dev Acquisition reported net income of $6.4M.

This page collects what Stock Titan holds for TDACU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$12.57
+8.83%
+1.02
Last updated: July 28, 2026 at 14:07
+10.7%
Performance 1 year

Translational Dev Acquisition (TDACU) stock last closed at $11.55. Over the past 12 months, the stock has gained 10.7%.

See what a $1,000 investment in TDACU would be worth today

TDACU Rankings

SEC Filings

Translational Dev Acquisition has filed 5 recent SEC filings, including 4 Form 8-K, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TDACU SEC filings →

Financial Highlights

operating income reached -$945K, and net income was $6.4M. The company generated -$608K in operating cash flow. With a current ratio of 0.07, short-term liquidity bears monitoring.

$6.4M
Net Income (FY2025)
-$608K
Operating Cash Flow
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Translational Dev Acquisition (TDACU) currently stands at 1 shares.

Days to Cover History

Last 12 Months

Days to cover for Translational Dev Acquisition (TDACU) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

TDACU Company Profile & Sector Positioning

Translational Dev Acquisition (TDACU) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ.

Investors comparing TDACU often look at related companies in the same sector, including Bold Eagle Acquisition Corp (BEAGU), Aldel Financial II (ALDFU), Cayson Acquisition Corp (CAPNU), Charlton Aria Acquisition Corp (CHARU), and Future Vision II Acquisition Corp (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TDACU's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Translational Dev Acquisition (TDACU)?

The current stock price of Translational Dev Acquisition (TDACU) is $11.55 as of July 16, 2026.

What is the net income of Translational Dev Acquisition (TDACU)?

The FY2025 net income of Translational Dev Acquisition (TDACU) is $6.4M, from its most recent completed fiscal year.

What is the operating cash flow of Translational Dev Acquisition (TDACU)?

The operating cash flow of Translational Dev Acquisition (TDACU) is -$608K. Learn about cash flow.

What is the current ratio of Translational Dev Acquisition (TDACU)?

The current ratio of Translational Dev Acquisition (TDACU) is 0.07, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Translational Dev Acquisition (TDACU)?

The operating income of Translational Dev Acquisition (TDACU) is -$945K. Learn about operating income.